TY - JOUR
TI - Polatuzumab vedotin for B-cell lymphoma
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2020
ET - 2020/10/22
VL - 43
IS - 6
SP - 218
EP - 219
DO - 10.18773/austprescr.2020.069
LA - eng
UR - https://australianprescriber.tg.org.au/articles/polatuzumab-vedotin-for-b-cell-lymphoma.html
KW - polatuzumab vedotin
KW - B-cell lymphoma
KW - Polivy
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -